Health Condition 1: J989- Respiratory disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Children whose parents are willing to give consent for clinical trial. 2) Children aged between 01 to 05 years of either sex. 3) Children with recurrent respiratory infections.
Exclusion criteria
Exclusion criteria: 1) Children suffering from major systemic illness necessitating long term treatment. 2) Children with evidence of malignancy, genetic or congenital anomaly. 3) Children with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4) Co-morbidity like TB, UTI and bleeding disorders etc. 5) H/o hypersensitivity to any of the trial drug or their ingredients. 6) Children who have completed participation in any other clinical trial during the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Ig GTimepoint: baseline and 56th day of starting of trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptomatic reliefTimepoint: every 14th day after intervention of drug | — |
Countries
India
Contacts
National Institute of Ayurveda